4A2-60729-89772 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-07-21
Dose 1 — Pfizer-BioNTech
2022-07-30
Registered in v-safe
2022-07-30
Health check-in — day 7, dose 1, dependent
Feeling: Good · Rash, not including the immediate area around the injection site

Adult check-in
2022-08-04
Survey response — day 14, dose 1, dependent
MedDRA: Lacrimation increased, Rhinorrhoea — Feeling: Good

Free text: Watery eyes and runny nose

MedDRA releases: 2024-11 · check-in free text available
2022-08-11
Dose 2 — Pfizer-BioNTech
2022-08-11
Health check-in — day 0, dose 2, dependent
Feeling: Good · None

Adult check-in
2022-08-12
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · Diarrhea

Adult check-in
2022-08-16
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-07-21	Pfizer-BioNTech	No
2	2022-08-11	Pfizer-BioNTech	No

Free text

Release 12 — day 14, dose 1, dependent

2022-08-04

Symptoms: Watery eyes and runny nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Lacrimation increased	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release